Breaking News

TOT Biopharm Opens Suzhou Production Facility

Completes first stage of construction

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

TOT Biopharm Co. Ltd. has completed the first stage of construction of its $100 million factory complex in eastern China’s Suzhou Industrial Park. The 50,000-sq.-m. facility complex specializes in the R&D, production and marketing of anti-cancer drugs globally. The company’s core products include liposomal technology-based specialty drugs, biologics and innovative drugs.   The first stage of the new factory complex includes an oral anti-cancer drug plant with separate production ...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters